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Antimicrobial agents are crucial for the treatment of many bacterial diseases
in pigs, however, the massive use of critically important antibiotics such as
colistin, fluoroquinolones and 3rd–4th-generation cephalosporins often selects for
co-resistance. Based on a comprehensive characterization of 35 colistin-resistant
Escherichia coli from swine enteric colibacillosis, belonging to prevalent Spanish
lineages, the aims of the present study were to investigate the characteristics of
E. coli clones successfully spread in swine and to assess the correlation of the in vitro
results with in silico predictions from WGS data. The resistome analysis showed
six different mcr variants: mcr-1.1; mcr-1.10; mcr-4.1; mcr-4.2; mcr-4.5; and mcr-
5.1. Additionally, blaCTX-M-14, blaCTX-M-32 and blaSHV-12 genes were present in seven
genomes. PlasmidFinder revealed that mcr-1.1 genes located mainly on IncHI2 and
IncX4 types, and mcr-4 on ColE10-like plasmids. Twenty-eight genomes showed a gyrA
S83L substitution, and 12 of those 28 harbored double-serine mutations gyrA S83L and
parC S80I, correlating with in vitro quinolone-resistances. Notably, 16 of the 35 mcr-
bearing genomes showed mutations in the PmrA (S39I) and PmrB (V161G) proteins.
The summative presence of mechanisms, associated with high-level of resistance to
quinolones/fluoroquinolones and colistin, could be conferring adaptive advantages to
prevalent pig E. coli lineages, such as the ST10-A (CH11-24), as presumed for ST131.
SerotypeFinder allowed the H-antigen identification of in vitro non-mobile (HNM) isolates,
revealing that 15 of the 21 HNM E. coli analyzed were H39. Since the H39 is associated
with the most prevalent O antigens worldwide within swine colibacillosis, such as
O108 and O157, it would be probably playing a role in porcine colibacillosis to be
considered as a valuable subunit antigen in the formulation of a broadly protective
Enterotoxigenic E. coli (ETEC) vaccine. Our data show common features with other
European countries in relation to a prevalent clonal group (CC10), serotypes (O108:H39,
O138:H10, O139:H1, O141:H4), high plasmid content within the isolates and mcr
location, which would support global alternatives to the use of antibiotics in pigs. Here,
we report for first time a rare finding so far, which is the co-occurrence of double
colistin-resistance mechanisms in a significant number of E. coli isolates.
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INTRODUCTION
Multidrug-resistant Enterobacteriaceae, such as Escherichia coli,
represent a threat to both human and veterinary health.
E. coli has a great capacity to accumulate resistance genes,
mostly through horizontal gene transfer. The major problematic
mechanisms correspond to the acquisition of genes coding
for extended-spectrum beta-lactamases (ESBL), carbapenemases,
16S rRNA methylases, plasmid-mediated quinolone resistance
(PMQR) and mcr genes conferring resistance to polymyxins
(Poirel et al., 2018).
Colistin has been widely used in Spain for the control of
neonatal and post-weaning diarrhoea (PWD) in pigs caused
by certain E. coli pathotypes: Enterotoxigenic E. coli (ETEC),
defined by the presence of genes encoding enterotoxins (eltA,
and/or estA, and/or estB); atypical Enteropathogenic E. coli
(aEPEC), carriers of eae but negative for bfpA (aEPEC);
Shiga toxin–producing E. coli (STEC), positive for stx2e;
STEC/ETEC, positive for both shiga toxin type 2e and
enterotoxin-encoding genes (stx2e and estB and/or estA) (García-
Meniño et al., 2018). PWD results in significant economic
losses for the pig industry due to costs derived of treatment
and handling, decreased weight gain, and mortality. These
circumstances have promoted the use and abuse of antibiotics in
intensive farming (Luppi, 2017; Rhouma et al., 2017). However,
specific regulations have been set up in Europe due to the
concern that colistin resistance could be transmitted from
food-production animals to humans which makes necessary
the investigation of sustainable alternatives to antimicrobials
(EUROPEAN COMMISSION, 2018).
In Spain, the rates of antibiotic resistance in pig farming were
recently analyzed in a collection of 499 E. coli isolates from
179 outbreaks of enteric colibacillosis occurred during a period
of 10 years (2006–2016) (García et al., 2018; García-Meniño
et al., 2018). The results revealed a prevalence of colistin-resistant
E. coli implicated in PWD in Spanish farms as high as 76.9%
within 186 ETEC, STEC and STEC/ETEC isolates. Besides, PCR
and sequencing identified the presence of mcr-4 in 102 isolates,
mcr-1 in 37 isolates and mcr-5 in five isolates. Interestingly,
almost all mcr-4 isolates belonged to the clonal group ST10-
A (CH11-24) (García et al., 2018), which was shown to be
highly present (more than 50%) within the mcr-1 diarrheagenic
isolates of a second study (García-Meniño et al., 2018). Both
studies reinforced other countries’ findings that the pig industry
is an important reservoir of colistin-resistant E. coli, as well
as being carriers of other additional risk genes such as blaESBL
genes (García et al., 2018; García-Meniño et al., 2018; Magistrali
et al., 2018; Manageiro et al., 2019). Based on reported evidences
(Beyrouthy et al., 2017; Gilrane et al., 2017), there is great
concern about the in vivo acquisition of mcr- and blaESBL-bearing
plasmids by human E. coli isolates following treatment with
colistin, or via animal transmission through direct contact or
via food chain. Particular attention is given to those named as
high-risk clones of (ESBL)-producing bacteria, worldwide spread
within humans and animals, including Escherichia coli sequence
types ST10, ST131, ST405, and ST648 (Mathers et al., 2015; Sellera
and Lincopan, 2019).
The aims of this study were (i) the characterization of
resistances and plasmid profiles of successfully spread mcr-1, mcr-
4, and mcr-5 E. coli in Spanish pig farming; (ii) the assessment
of WGS-based approaches for the characterization of pathogenic
E. coli, through the correlation of the in vitro results with in silico




Thirty-five swine E. coli, positive by PCR for mcr-genes, were
fully sequenced. Specifically, the 35 E. coli were selected from
499 diarrheagenic isolates of different geographic areas of Spain
(2006–2016) (García et al., 2018; García-Meniño et al., 2018),
taking into account the results of prevalence and significant
association observed between pathotypes, presence of mcr and
certain serogroups. In brief, the serogroups O108, O138, O141,
O149, O157 were found significantly associated with ETEC;
serogroups O26, O49, O80, O111 with aEPEC; serogroups O138
and O141 with STEC/ETEC; serogroup O139 with STEC; and
serogroups O2, O15, O26, O45, O111, O138, O141, O157 with
mcr-positive isolates (García-Meniño et al., 2018). Therefore,
the collection analyzed here included 27 ETEC isolates (of
serogroups O7, O8, O15, O45, O108, O138, O141, O149,
O157, ONT); four STEC (O2, O139); three STEC/ETEC (O138
and O141) and one aEPEC (O111). The 35 representative
isolates were carriers of the three mcr-types (mcr-1, mcr-4,
and mcr-5) detected so far in our E. coli collection of porcine
origin. Conventional pheno- and geno-typing was performed
to complete classical characterization of serotypes, phylogroups,
pathotypes and resistance profiles.
Conventional Typing
The H antigen was established for motile isolates by serotyping
using H1 to H56 antisera, while non-motile isolates (HNM) were
analyzed by PCR to determine their flagellar genes as described
elsewhere (García-Meniño et al., 2018). The phylogroup
was assigned by means of the quadruplex PCR of Clermont
et al. (2013). Antimicrobial susceptibility was determined
by minimal inhibitory concentrations (MICs) using the
MicroScan WalkAway R©-automated system (Siemens Healthcare
Diagnostics, Berkeley, CA, United States) according to the
manufacturer’s instructions for: amikacin, ampicillin-sulbactam,
aztreonam, cefepime, ceftazidime, ciprofloxacin, colistin,
fosfomycin, gentamicin, imipenem, levofloxacin, meropenem,
minocycline, nitrofurantoin, piperacillin-tazobactam, ticarcillin,
tigecycline, and tobramycin. Additionally, resistance to
ampicillin, amoxicillin/clavulanate, cefazolin, cefotaxime,
cefoxitin, cefuroxime, chloramphenicol, doxycycline, nalidixic
acid and trimethoprim-sulfamethoxazole was determined by
disk (Becton Dickinson, Sparks, MD, United States) diffusion
assays. All results were interpreted according to the CLSI break
points (Clinical and Laboratory Standards Institute, 2019).
Genetic identification of the ESBLs was performed by PCR using
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the TEM, SHV, CTX-M-1 and CTX-M-9 group-specific primers
followed by amplicon sequencing (García-Meniño et al., 2018).
Whole Genome Sequencing (WGS) and
Sequence Analysis
The libraries for sequencing were prepared following the
instructions provided by the TruSeq Illumina PCR-Free protocol.
Mechanical DNA fragmentation was performed with Covaris
E220, and the final quality of the libraries assessed with
Fragment Analyzer (Std. Sens. NGS Fragment Analysis kit 1-
6000 bp). Lastly, the libraries were sequenced in an Illumina
HiSeq1500, obtaining 100–150 bp paired-end reads which were
trimmed (Trim Galore 0.5.0) and filtered according to quality
criteria (FastQC 0.11.7). The reconstruction of the genomes
and plasmids in the genomes was carried out using the
methodology PLAsmid Constellation NETwork (PLACNETw)1
(Lanza et al., 2014). The assembled contigs, with genomic
size ranging between 4.9 and 5.9 Mbp (mean size 5.5 Mbp),
were analyzed using the bioinformatics tools of the Center for
Genomic Epidemiology (CGE)2 for the presence of antibiotic
resistance (ResFinder V2.1.), virulence genes (VirulenceFinder
v1.5.), plasmid replicon types (PlasmidFinder 1.3./PMLST 1.4.),
and identification of clonotypes (CHTyper 1.0), sequence
types (MLST 2.0) and serotypes (SerotypeFinder 2.0). All the
CGE predictions were called applying a select threshold for
identification and a minimum length of 95 and 80%, respectively.
Phylogroups were predicted using the ClermonTyping tool at
the iame-research center web3. The mcr gene location was
determined using PlasmidFinder/ResFinder prediction, together
with PLACNETw references, and automatic annotation with
Prokka v1.13 (Seemann, 2014).
RESULTS AND DISCUSSION
The phenotypic and genotypic traits of the 35 mcr-positive
E. coli of swine origin, as well as their resistome and mobilome
are summarized in Table 1. ResFinder confirmed that all
genomes were mcr carriers. Likewise, VirulenceFinder predicted
the acquired virulence genes encoding for the enterotoxins
(sta1, stb, itcA), for fimbriae (fedF, k88), verotoxin (stx2)
and intimin (eae), correlating in all cases with the pathotype
assignation previously determined by PCR (García et al., 2018;
García-Meniño et al., 2018).
Serotype Identification
In most studies, there is lack of information on E. coli serotypes
since serotyping is performed by very few laboratories worldwide,
hindering epidemiological comparisons. Here, we not only
proved that there is a very good correlation between serotyping
and SerotypeFinder predictions, but also the advantage of in silico
H-antigen identification for those non-mobile (HNM) isolates.




as H39 (Table 1), namely O108:H39, O157:H39 and O45:H39
(five genomes, each). Given that the H39 is associated with the
most prevalent O antigens within swine colibacillosis, such as
O108 and O157, as well as ONT (García-Meniño et al., 2018),
it would be probably playing a role in porcine colibacillosis to
be considered as a valuable subunit antigen in the formulation
of a broadly protective ETEC vaccine (Roy et al., 2009). The
remaining six HNM isolates showed different O:H combinations:
O138:H14, ONT:H5, O8:H20, O50/O2:H32, and O182:H19.
SerotypeFinder also allowed the O45-antigen determination of
two non-typeable (ONT) isolates (LREC-141 and LREC-146)
and O182 of LREC-172; while LREC-147, belonging to O157
serogroup (Table 1), was predicted as ONT, probably due to
the limitation of the assembly based on Illumina short reads
(100–150 bp paired-end reads here) (Wick et al., 2017).
Phylogroups, Sequence Types and
Clonotypes
The phylogroups established for the 35 genomes were the
common ones reported for porcine E. coli isolates (A, B1, D-E)
(Shepard et al., 2012; Bosak et al., 2019). However, we found
discrepancies in the assignation obtained with the quadruplex
PCR of Clermont et al. (2013) in comparison with that predicted
by ClermonTyping for seven isolates: phylogroup E by PCR, while
phylogroup D in silico (Table 1).
MLST and CHTyper tools determined 12 different STs, but
mostly belonging to CC10 (21 genomes) and clonotype CH11-
24 (18 genomes) (Table 1). The predominance of CC10, and
specifically ST10, is in accordance with published data on E. coli
isolates of swine origin, independently of the pathogenicity or
antibiotic-resistance/susceptibility status (Shepard et al., 2012;
Kidsley et al., 2018; Magistrali et al., 2018).
Resistome, Plasmidome and Phenotypic
Expression of Resistances
The resistome analysis revealed that 34 of the 35 genomes
encoded mechanisms of antibiotic resistance for≥three different
antimicrobial categories (Table 1). Seven E. coli were carriers of
blaESBL, namely blaCTX-M-14 (four genomes), blaCTX-M-32 (one)
and blaSHV-12 (two). Besides, six different mcr variants were
identified within the 35 E. coli: mcr-1.1 (in 18 genomes, including
two mcr-4.2 carriers); mcr-1.10 (one); mcr-4.1 (one); mcr-4.2 (13
genomes, including the two mcr-1.1 carriers); mcr-4.5 (two) and
mcr-5.1 (two).
PlasmidFinder revealed a high plasmid diversity based on
the identified replicons, with two to seven different plasmid
types per genome (Table 1). Within this heterogeneity, mcr-
1.1 genes were found mainly on plasmids of the IncHI2
and IncX4 types (six and four of the 12 mcr-1.1 plasmid-
located genes, respectively); however, mcr-1.1 was also found
integrated in the chromosome of LREC-145, LREC-148,
LREC-149 and LREC-164 genomes. The mcr-1.10 gene of
LREC-151 was located on the chromosome, while mcr-4
and mcr-5 variants were on Col8282-like (mcr-4.1), ColE10-
like (for all 13 mcr-4.2 and two mcr-4.5 carriers) and
pKP13a-like (mcr-5.1) plasmids. Furthermore, we found that
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1Year of isolation of the WGS isolates recovered from pig colibacillosis. 2Serotypes, 4clonotypes, 5sequence types, 6replicon/plasmid STs, 7acquired antimicrobial resistance genes and/or chromosomal mutations,
9virulence genes were determined using SerotypeFinder 2.0, CHtyper 1.0, MLST 2.0, PlasmidFinder 2.0, pMLST 2.0, ResFinder 3.1 and VirulenceFinder 2.0 online tools at the Center of Genomic Epidemiology
(https://cge.cbs.dtu.dk/services/), respectively; while 3phylogroups were predicted using the ClermonTyping tool at the Iame-research Center web (http://clermontyping.iame-research.center/).2Serotypes: underlined
those antigens that were non-typeable (ONT or HNM) by conventional serotyping but determined by SerotypeFinder. ∗LREC-147 was solved as O157 by conventional typing. 3Phylogroups: “∗D” indicates that LREC-
133, LREC-134, LREC-143, LREC-151, LREC-170, LREC-171, LREC-174 revealed discrepancies between the assignation obtained with the quadruplex PCR of Clermont et al. (2013) and the in silico assignation
using ClermonTyping tool, showing phylogroup E by PCR, but phylogroup D in silico. 6Plasmid STs: “∗” indicates alleles with less than 100% but >95% identity and 100% coverage; “/” indicates alleles with multiple
perfect hits found. 7Resistome: chromosomic and plasmid mechanisms associated to colistin resistance are highlighted in bold. Genes coding for ESBLs appear underlined. Acquired resistance genes: beta-lactam:
blaTEM-1B, blaTEM-1A, blaOXA-1, blaCTX-M-14, blaCTX-M-32, blaSHV-12, aminoglycosides: aac(3)-II/IV, acc(6′)-Ib3, aadA, aph(3′)-I/IIa, aph(3′ ′)-Ib, aph(4)-Ia, aph(6)-Id; phenicols: catA1, catB3, cmlA1, floR; fluoroquinolones:
aac(6′)-Ib-cr, qnrS1; macrolides: erm(B), inu(F), inu(G), mdf(A), mph(B); sulfonamides: sul1, sul2, sul3; tetracycline: tet(A), tet(B), tet(M); trimethoprim: dfrA1, dfrA12. Point mutations: quinolones and fluoroquinolones:
gyrA S83L: TCG-TTG, gyrA D87G: GAC-GGC, gyrA D87N: GAC-AAT, gyrA D87Y: GAC-TAT, parC S80I: AGC-ATC, parC S80R: AGC-AGG, parC E84G: GAA-GGA, parE L416F: CTT-TTT; colistin: pmrB V161G:
GGG-GTG, pmrA S39I: AGC-ATC. 8The mcr gene location was determined using PlasmidFinder/ResFinder predictions, together with PLACNETw building and references (https://castillo.dicom.unican.es/upload/),
and Prokka annotations. 9Highlighted in bold, those features defining E. coli pathotypes (STEC, ETEC, EPEC). Virulence genes: itcA, coding for heat labile enterotoxin A subunit; sta1, heat stabile enterotoxin ST-Ia;
stb, heat stabile enterotoxin II; fedF, fimbrial adhesin AC precursor; K88, K88/F4 protein subunit; air, enteroaggregative inmunoglobulin repeat protein; astA, EAST-1; capU, hexosyltransferase homolog; cba, colicin
B; celB, endonuclease colicin E2; cif, type III secreted effector; cma, colicin M; eae, intimin; efa1, EHEC factor for adherence; eilA, Salmonella HilA homolog; espA, type III secretions system; espB, secreted protein
B; espF, type III secretions system; espJ, prophage -encoded type III secretion system effector; etpD, type II secretion protein; fedA, F107; gad, glutamate descarboxylase; iha, adherence protein; iroN, enterobactin
siderophore receptor protein; iss, increased serum survival; lpfA, long polar fimbriae; nleA, non LEE encoded effector A; nleB, non-LEE encoded effector B; sepA, Shigella extracellular protein A; tccP, Tir cytoskeleton
coupling protein; tir, translocated intimin receptor protein. bp, base pairs; CHType, clonotype (fumC-fimH); ST (CC), sequence type and clonal complex according to Achtman scheme; pMLST, plasmid sequence type.
10Phenotypic resistances interpreted according to the CLSI (intermediate resistance is indicated with an asterisk ∗). AMC, amoxicillin/clavulanate; AMP, ampicillin; AMP/SAM, ampicillin-sulbactam; ATM, aztreonam;
CAZ, ceftazidime; CHL, chloramphenicol; CIP, ciprofloxacin; CST, colistin; CTX, cefotaxime; CXM, cefuroxime; CFZ, cefazolin; DOX, doxycycline; FEP, cefepime; FOF, fosfomycin; GEN, gentamicin; LVX, levofloxacin;
MI, minocycline; NAL, nalidixic acid; NIT, nitrofurantoin; SXT, trimethoprim/sulfamethoxazole; TIC, ticarcillin; TOB, tobramycin. 11Pathotype of the isolates, established by conventional PCR, based on specific genes
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there was no mcr plasmid co-occurrence in LREC-141 and
LREC-163, but rather the mcr-1.1 and mcr-4.2 genes were
located in independent plasmids (IncHI2 and ColE10-like
types, respectively). The mcr location remained undetermined
for four isolates.
Since the mcr-1 plasmid gene was first described (Liu et al.,
2016), it has been identified in members of the Enterobacteriaceae
family encoded in different plasmid types, including IncI2, IncX4,
IncHI1, IncHI2, IncFI, IncFII, IncP, IncK (Sun et al., 2018).
Different authors corroborate that large conjugative plasmids
of types IncHI2, IncX4 and IncI2 would be the maximum
responsible for the dissemination of the mcr-1 gene among
E. coli isolates from different sources and geographical locations
(Doumith et al., 2016; Li et al., 2017; Manageiro et al., 2019). To
date, other mcr genes (2–9) have been described (Carroll et al.,
2019); among them, the mcr-4 and mcr-5 genes appear mostly
encoded in small and non-conjugative ColE-like type plasmids
(Sun et al., 2018). Here we found similar results, since mcr-
1.1 genes were located mainly on IncHI2 and IncX4 types, and
mcr-4 on ColE10-like plasmids. It is of note that the mcr-5.1
gene, predicted in LREC-152 and LREC-177, was linked to a
Kp13-like plasmid (CP003996.1), location previously described
by Hammerl et al. (2018) for one mcr-5 isolate recovered from a
fecal pig sample at farm. Chromosomally-encoded mcr-1 location
remains rare, however, it was described soon after the discovery
of this plasmid-borne gene (Falgenhauer et al., 2016; Veldman
et al., 2016). Here, we determined chromosomal location in
five genomes by means of PLACNETw, and according to the
predictive annotation of the mcr-contigs, the only common
element flanking the mcr-1 was a putative ORF, pap2, which
is part of the Tn6360 and encodes a Pap2 superfamily protein.
Thus, Pap2 was detected in LREC-145, LREC-148, LREC-149,
and LREC-164, while the ISApI1 element typically associated with
the initial mobilization of mcr-1, was missing within the five
contigs (Snesrud et al., 2018).
Overall, our findings are in accordance with those reported
by Magistrali et al. (2018) on 13 mcr-positive E. coli isolated
from swine colibacillosis in Belgium, Italy and Spain. Both
studies show common features in relation to a prevalent
clonal group (CC10), serotypes (O108:H39, O138:H10, O139:H1,
O141:H4), and mcr-plasmid types. The confirmation of these
similarities are of interest for the global design of alternatives to
antibiotics that would curb the dissemination of specific clones in
the pig farming.
The in vitro analysis of resistances showed that 30 of the 35
E. coli were multidrug-resistant (MDR) according to Magiorakos
et al. (2012) definition (Table 1). Phenotypic results corresponded
broadly to those predicted by ResFinder (Supplementary Table
S1) as detailed below.
The quinolones/fluoroquinolones (FQ), together with
polymyxins and 3rd–4th-generation cephalosporins, all are
included in Category B of restricted antimicrobials in the
EMA categorization, considering that the risk to public health
resulting from its veterinary use needs to be mitigated by specific
restriction (EMA/CVMP/CHMP, 2019). Two major mechanisms
are implicated in the resistance to FQ, namely, mutations in
the genes for DNA gyrase and topoisomerase IV, and decreased
intracellular drug accumulation. In addition, plasmid-mediated
quinolone resistances also play a role but usually conferring low-
level FQ resistance (van Duijkeren et al., 2018). Phenotypically,
17 of the 35 isolates showed resistance to both nalidixic acid and
ciprofloxacin, and other eight resistance to nalidixic acid only
(Supplementary Table S1). In the majority of cases, phenotypic
results correlated with those predicted by ResFinder. Particularly,
28 of the 35 genomes carried the gyrA S83L substitution, with
12 of those 28 showing double-serine mutations (gyrA S83L and
parC S80I). An additional substitution (gyrA D87N) was detected
in two of the 12 gyrA S83L/parC S80I genomes. Thus, nalidixic
acid resistance in vitro corresponded to one single substitution
(gyrA S83L), and FQ resistance to double or triple substitutions
(gyrA S83L/parC S80I/gyrA D87N). Plasmid-mediated quinolone
resistant genes acc(6′)-Ib-cr and qnrS1 were also present together
with chromosomal mutations in LREC-147 and LREC-169,
respectively. Double-serine mutations in specific positions of the
gyrA and parC genes have been reported as a dominant feature
of MDR lineages within E. coli, S. aureus and K. pneumoniae,
with favorable fitness balance linked to high levels of resistance
to FQ (Fuzi et al., 2017). This finding, in 12 out of the 28
in silico predicted FQ-resistant could be conferring adaptive
advantages to certain widely spread pig pathogenic clonal groups
of E. coli, such as the ST10-A (CH11-24) (García et al., 2018).
This hypothesis is presently assumed for ST131 and other
risk clones linked to high FQ-resistance (Johnson et al., 2015;
Fuzi et al., 2017).
On the other hand, colistin has been widely used for the
control of enteric diseases, mainly in swine and poultry (Rhouma
et al., 2016; Hammerl et al., 2018). Several mechanisms of
resistance due to chromosomal mutations or acquired resistance
genes have been described so far (Olaitan et al., 2014; Poirel et al.,
2018). The 35 colistin-resistant E. coli of this study showed MIC
values > 4 mg/L. As detailed above, ResFinder confirmed that
all the analyzed genomes were mcr-carriers. In addition to the
plasmid mechanism (mcr) of resistance, polymyxin resistance in
E. coli can be due to genes encoding LPS-modifying enzymes,
particularly to mutations in the two-component systems PmrAB
and PhoPQ, or in the MgrB regulator. Quesada et al. (2015)
detected two colistin-resistant E. coli recovered in 2011 and
2013 from the stools of two pigs, which showed mutations in
PmrB V161G and PmrA S39I, reporting the finding as a rare
event. Subsequently, Delannoy et al. (2017) analyzed 90 strains
of E. coli isolated from diseased pigs: 81 were phenotypically
resistant to colistin and 72 mcr-1 carriers (including two colistin-
susceptible). Although different mutations were found in the
amino acid sequences of the MgrB, PhoP, PhoQ, and PmrB
proteins of eight isolates, only two of them were mcr-1 positive
(but colistin-susceptible). Surprisingly, we found here the double
mechanism of colistin resistance in 16 E. coli, harboring mcr-
genes together with one amino acid substitution: PmrB V161G
(14 genomes) or PmrA S39I (two genomes). In a recent study
on Parisian inpatient fecal E. coli (Bourrel et al., 2019), the
authors found 12.5% of colistin-resistant E. coli carriers among
1,217 patients; however, mcr-1 gene was identified in only seven
of 153 isolates, while 72.6% harbored mutations in the PmrA
and PmrB proteins. According to the authors, their findings
Frontiers in Microbiology | www.frontiersin.org 10 November 2019 | Volume 10 | Article 2469
fmicb-10-02469 October 31, 2019 Time: 18:39 # 11
García-Meniño et al. WGS of mcr-1, mcr-4, and mcr-5 E. coli
indicate two evolutionary paths leading to colistin resistance
in human fecal E. coli, one corresponding to a minority of
plasmid-encoded mcr-1 isolates of animal origin, and a second
corresponding to a vast majority of human isolates exhibiting
chromosomally encoded mechanisms (Bourrel et al., 2019). Thus,
and given the limited data regarding the co-occurrence of double
resistance mechanism, it is of note that 16 of the 35 mcr-bearing
genomes of our study showed mutations in the PmrA and
PmrB proteins. Furthermore, two E. coli (LREC-141 and LREC-
163) shown to be carriers of two different mcr-bearing plasmids
together with PmrB V161G mutation. An explanation for this
rare finding is that these isolates would be reflecting a cumulative
evolution to antibiotic pressure and, as a consequence, enhancing
the transmission (vertical and horizontal) of colistin resistance.
In any case, further investigation is needed to evaluate the
implication of chromosomal mutations and mcr co-occurrence
regarding colistin resistance phenotype.
In this study, 22 out of the 25 isolates showing phenotypic
resistance to beta-lactams (Supplementary Table S1), were
positive in the analysis in silico for the presence of blaTEM-1 genes,
alone (14 genomes), or in combination with other bla genes
(blaCTX-M-14, blaSHV-12, blaCTX-M-32 and blaOXA-1); additionally,
two genomes showed the presence of blaCTX-M-14 and blaSHV-12,
respectively. With the exception of LREC-147, LREC-164, and
LREC-170, which were phenotypically resistant to narrow-
spectrum beta-lactamases but negative for the presence of genes,
a good correlation was observed between genes predicted and
resistance shown in vitro. It is of note that blaTEM-135, determined
in LREC-156 by conventional typing, was not identified in silico.
Beta-lactams are the most widely used family in current clinical
practice. Numerous genes in E. coli confer resistance to this
group, being some of them, such as blaTEM-1 widespread in E. coli
from animals coding for narrow-spectrum beta-lactamases that
can inactivate penicillins and aminopenicillins. However, genes
encoding ESBLs/AmpCs have increasingly emerged in E. coli
from humans and animals, including food-producing animals
(Cortes et al., 2010).
Thirty out of the 35 genomes showed high frequency
of resistance genes to aminoglycosides, specifically encoding
AAC(3)-II/IV and AAC(6)-Ib, which are the most frequently
encountered acetyltransferases among E. coli of human and
animal origins. The subclass AAC(3)-II, which is characterized
by resistance to gentamicin, netilmicin, tobramycin, sisomicin,
2′-N-ethylnetilmicin, 6′-N-ethylnetilmicin and dibekacin (Shaw
et al., 1993), and AAC(6′) enzymes that specify resistance
to several aminoglycosides and differ in their activity against
amikacin and gentamicin C1 (Ramirez and Tolmasky, 2010)
seemed to correlate with the phenotypic detection of resistance
to gentamicin and/or tobramycin (12 of the 17 resistant isolates)
(Supplementary Table S1). We also detected high prevalence
of genes encoding nucleotidyltransferases (aadA), which specify
resistance to spectinomycin and streptomycin, alone or together
with phosphotransferases (APHs) (Ramirez and Tolmasky,
2010), but they were not tested in the phenotypic antimicrobial
susceptibility tests.
It is noteworthy that the 35 genomes of our study were
carriers of mdf(A). Edgar and Bibi (1997) described that cells
expressing MdfA from a multicopy plasmid are substantially
more resistant to a diverse group of cationic or zwitterionic
lipophilic compounds. Besides, the authors found that MdfA also
confers resistance to chemically unrelated, clinically important
antibiotics such as chloramphenicol, erythromycin, and certain
aminoglycosides and fluoroquinolones. This capability could
correlate with the in vitro resistance observed for some isolates
to tetracyclines and aminoglycosides, in absence of other
specific genes. In our collection, of the 24 isolates showing
phenotypic resistance to minocycline and, or doxycycline
(Supplementary Table S1), 20 showed carriage of tet genes: 12
tet(B), six tet(A), one tet(A) + tet(B) and one tet(B) + tet(M).
However, two tet(A) isolates were susceptible to those antibiotics
(LREC-163, LREC-169). Additionally, tet genes were not
detected in silico in four phenotypically resistant isolates. In
general, tet(A) and tet(B) are the most prevalent tetracycline
resistance genes in E. coli of animal origin, and specifically
in isolates from pigs (Tang et al., 2011; Holzel et al., 2012;
Jurado-Rabadan et al., 2014).
Although the use of chloramphenicol was banned in the
European Union in food-producing animals in 1994, fluorinated
derivative florfenicol is allowed for the treatment of bacterial
infection in these animals (Schwarz et al., 2004; OIE, 2019).
In the present study, all 19 chloramphenicol-resistant isolates
(Supplementary Table S1) correlated with the presence of genes
catA1 (12 genomes), catB3 (one genomes), cmlA (ten genomes) or
floR (three genomes) detected in silico. Travis et al. (2006) showed
that chloramphenicol resistant genes are frequently linked to
other antibioresistance genes. Thus, through transformation
experiments conducted with E. coli from pigs demonstrated
that aadA and sul1 were located with catA1 on a large ETEC
plasmid, and plasmids carrying cmlA also carried sul3 and aadA.
According to the authors, this linkage might partly explain the
long-term persistence of chloramphenicol resistance in ETEC
despite its withdrawal years ago. In our study, ResFinder also
showed an association of genes cmlA, sul3 and aadA present in
the same contig (7 of the 10 genomes positive for cmlA), and
cmlA/aadA in all cases. Additionally, aadA and sul1 were located
with floR in LREC-146.
In E. coli from food-producing animals, sulfonamide
resistance is mediated by sul genes (sul1, sul2, sul3),
widely disseminated, and frequently found together with
other antimicrobial resistance genes, while dfr genes
confer trimethoprim resistance in E. coli and other gram-
negative bacteria (van Duijkeren et al., 2018). Within our
collection, 20 of the 35 isolates were in vitro resistant to
trimethoprim/sulfamethoxazole (Supplementary Table S1), and
most of them correlated with the presence of sul + dfrA genes in
their genomes, with the exception of LREC-133 and LREC-170
(negative for the in silico detection of sul, dfrA genes) and LREC-
146 (in which only sul1 and sul2 genes were predicted). Besides,
ResFinder showed that sul1 (present in 16 genomes), sul3 (14
genomes) and sul2 (three genomes) were located together with
dfrA, and other resistance genes, as mentioned previously.
The fosfomycin resistance showed in vitro by two isolates
of the study collection, was not predicted for LREC-144 and
LREC-145 (Supplementary Table S1) by ResFinder, which
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analyzes the presence of fos genes encoding for fosfomycin-
modifying enzymes. The use of this antibiotic has been limited
to the treatment of infections by Gram-positive and negative
pathogens, included E. coli, mainly in pig and poultry farming
(Poirel et al., 2018). However, phosphonic acid derivates such
as fosfomycin, have been recently categorized by the EMA
(EMA/CVMP/CHMP, 2019) as Category A (antimicrobial classes
not currently authorized in veterinary medicine in EU).
CONCLUSION
Swine colibacillosis control has been traditionally managed
through the extensive use of antibiotics. Our results are a
reflection of the situation within the industrial pig farming,
where global hygiene procedures and vaccinations are essential
for improvement in antimicrobial stewardship. The summative
presence of antibioresistances could be conferring adaptive
advantages to prevalent pig E. coli lineages, such as the
ST10-A (CH11-24). Based on the different replicons identified
by PlasmidFinder (up to seven), it is of note the high
plasmid diversity found within these isolates; further research
is needed to know mechanisms of maintenance and advantages
conferred to them.
Here, we report for first time a rare finding so far, which
is the co-occurrence of double colistin-resistance mechanisms
(mcr-genes and chromosomal mutations in the PmrA and PmrB
proteins) in a significant number of E. coli isolates. This fact
could be increasing the risk of colistin resistance-acquisition by
means of food transmission. Globally, we found a very good
correlation between resistances determined in vitro and genes
predicted using CGE tools, and the same observation applies to
the E. coli pathotype determination.
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